Steik Jason Paul
SEC CIK 2078374 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PNTG | Pennant Group, Inc. | Chief Clinical Off | 15.1K | — | $53.7K | 1 | 2026-08-06 | 2026-08-06 |
Most active insiders at PNTG, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Guerisoli Brent | CEO | — | $582.7K |
| 2 | Steik Jason Paul | Chief Clinical Off | — | $53.7K |
| 3 | Cheney Kirk Sterling | EVP, GC, Corp Secy | — | $53.7K |
| 4 | Walbom Lynette | CFO | — | — |
| 5 | Morris Gregory K Sr. | Dir | — | — |
| 6 | Gochnour John J | COO | — | — |
| 7 | Snapper Suzanne D. | Dir | — | — |
| 8 | Nackel John G. | Dir | — | — |
| 9 | Christensen Christopher R. | Dir | — | — |
| 10 | Lamb Scott E | Dir | — | — |
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-10 15:48 | 2026-08-06 | PNTG | Pennant Group, Inc. | Steik Jason Paul | Chief Clinical Off | S - Sale | $38.52 | -1,394 | 15.1K | -8% | -$53.7K |
Purchase Sale Sale after option exercise All abbreviations